BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29274670)

  • 1. Prediction of organ-confined disease after robot-assisted radical prostatectomy in patients with clinically locally-advanced prostate cancer.
    Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
    Asian J Surg; 2019 Jan; 42(1):120-125. PubMed ID: 29274670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Propensity score comparison of the various radical surgical techniques for high-risk prostate cancer].
    Busch J; Gonzalgo M; Leva N; Ferrari M; Friedersdorff F; Hinz S; Kempkensteffen C; Miller K; Magheli A
    Aktuelle Urol; 2015 Jan; 46(1):45-51. PubMed ID: 25526221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of positive preoperative biopsy cores is a predictor of positive surgical margins (PSM) in small prostates after robot-assisted radical prostatectomy (RARP).
    Tuliao PH; Koo KC; Komninos C; Chang CH; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2015 Dec; 116(6):897-904. PubMed ID: 25098818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy.
    Bütow Z; Schunk S; Janssen M; Gräber S; Saar M; Kamradt J; Siemer S; Stöckle M; Ohlmann CH
    Urol Int; 2015; 95(4):465-71. PubMed ID: 26575991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
    Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
    Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
    BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
    Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
    Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
    Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.
    Santok GD; Abdel Raheem A; Kim LH; Chang K; Lum TG; Chung BH; Choi YD; Rha KH
    Investig Clin Urol; 2017 Mar; 58(2):90-97. PubMed ID: 28261677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and oncological outcomes in patients with a preoperative PSA value <4 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Labanaris AP; Bauer RM; Witt JH
    Anticancer Res; 2012 May; 32(5):2079-83. PubMed ID: 22593492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters.
    Shikanov SA; Thong A; Gofrit ON; Zagaja GP; Steinberg GD; Shalhav AL; Zorn KC
    J Endourol; 2008 Jul; 22(7):1477-81. PubMed ID: 18613786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
    Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
    Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.